3350 Scott Blvd., Building 36A
Santa Clara, California


Booth: 1015

Showcase presenter


Platform Nanoparticle-Imaging-Delivery Technology

Technology Area: Pharmaceuticals & Personal Care

Commercial Maturity: Commercial Product

Abstract: Our technology is based on a versatile platform technology providing nanoparticles with extremely enhanced permeability and retention; showing cancer region accumulation time >30 days with single dose in small animal xenograft model; with controllable pharmacokinetics, all FDA approvable component material, and superior magnetic, fluorescent, and cancer targeting properties.